Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy

BMC Cancer. 2023 Feb 9;23(1):133. doi: 10.1186/s12885-022-10491-w.

Abstract

Background: Transporter associated with antigen processing 1 (TAP1) is a molecule involved in processing and presentation of major histocompatibility complex class I restricted antigens, including tumor-associated antigens. TAP1 participates in tumor immunity, and is aberrantly expressed in multiple cancer types; METHODS: Transcriptome profiles were obtained from The Cancer Genome Atlas and Genotype-Tissue Expression databases. Genetic alterations, protein distribution, and interaction information for TAP1 were downloaded from cBioPortal, Human Protein Atlas and Compartmentalized Protein-Protein Interaction, respectively. Single-cell analyses of TAP1 across cancers were conducted via the Tumor Immune Single-cell Hub website. Gene set enrichment analysis was employed to investigate TAP1-associated functional mechanisms and processes. Immune cell infiltration was explored using Tumor Immune Estimation Resource 2.0. Pan-cancer correlations between TAP1 expression and immunotherapy biomarkers were explored using the Spearman's correlation test. Associations with immunotherapy responses were also investigated using clinicopathological and prognostic information from cohorts of patients with cancer receiving immune checkpoint inhibitors.

Results: TAP1 expression was elevated in most cancer types and exhibited distinct prognostic value. Immune cells expressed more TAP1 than malignant cells within most tumors. TAP1 expression was significantly correlated with immune-related pathways, T-lymphocyte infiltration, and immunotherapeutic biomarkers. Clinical cohort validation revealed a significant correlation with immune therapeutic effects and verified the prognostic role of TAP1 in immunotherapy. Western blot assay indicated that TAP1 is upregulated in glioblastoma compared with adjacent normal brain tissues.

Conclusion: TAP1 is a robust tumor prognostic biomarker and a novel predictor of clinical prognosis and immunotherapeutic responses in various cancer types.

Keywords: Cancer immunotherapy; Immune Check-point Inhibitor (ICI); Pan-cancer; Prognostic biomarker; Transporter associated with antigen processing 1 (TAP1).

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 2 / genetics
  • Antigen Presentation*
  • Biomarkers, Tumor
  • Blotting, Western
  • Glioblastoma*
  • Humans
  • Immunotherapy
  • Membrane Transport Proteins
  • Prognosis

Substances

  • Biomarkers, Tumor
  • Membrane Transport Proteins
  • TAP1 protein, human
  • ATP Binding Cassette Transporter, Subfamily B, Member 2